• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Let's Take a Look at Pfizer Partner BioNTech's Charts

Aggressive traders who have dug into the fundamentals of this German-based company could look to go long.
By BRUCE KAMICH
Nov 10, 2020 | 10:52 AM EST
Stocks quotes in this article: PFE, BNTX

Pfizer (PFE) seemed to get all the attention yesterday when they announced that their two-dose Covid-19 vaccine trial showed a 90% effective rate. Pfizer partner BioNTech (BNTX) is credited for contributing the messenger RNA technology. Messenger RNA is above my pay grade so what about their charts? 

 
In this daily Japanese candlestick chart of BNTX, below, we can see that prices have been in an uptrend the past 12 months. Prices are up more than five-fold in the past year. BNTX is trading above the rising 50-day moving average line and the limited 200-day moving average line.
 
Monday's candle pattern is red which tells us that despite the news prices closed below the opening. The trading volume started to increase back in March when the two companies agreed to develop the vaccine together.
 
The On-Balance-Volume (OBV) line moved up into July and then corrected before rising again. Overall the movement of the OBV line tells us that buyers of BNTX have been more aggressive.
 
The trend-following Moving Average Convergence Divergence (MACD) oscillator crossed to the upside yesterday for a fresh outright buy signal. 
 
 
 
In this weekly Japanese candlestick chart of BNTX, below, we can see a positive picture. Prices are in an uptrend above the rising 40-week moving average line.
 
The weekly OBV line is rising and the MACD oscillator is bullish.  
 
 
In this daily Point and Figure chart of BNTX, below, we can see that prices reached an upside price target of $112. 
 
 
In this weekly Point and Figure chart of BNTX, below, we can see a longer-term potential price target in the $170 area. 
 
Bottom line strategy: The best time to go long BNTX was back in March so now we can only suggest a less than perfect time and location. Aggressive traders who have dug into the fundamentals of this German based company could look to go long close to $105 risking below $90. The $170 area is the Point and Figure target. 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Drug Approvals | Investing | Stocks | Technical Analysis | Trading | Pharmaceuticals | Science | Mad Money | Coronavirus

More from Investing

With XL Fleet, Options Are Your Friend in Order to Define Risk

Timothy Collins
Feb 25, 2021 2:37 PM EST

If the market stabilizes, I believe XL could excel to the upside.

Let Retrace Back to Nvidia After Earnings

Bruce Kamich
Feb 25, 2021 2:23 PM EST

Here's what the the charts are saying now for the tech company.

As Plug Power Plummets, There Appears to Be More Risk Ahead

Bruce Kamich
Feb 25, 2021 2:03 PM EST

Let's check out the PLUG charts as traders react to the latest EPS numbers.

Ring the Cowbell: Here Are Three Ways to Play the Jittery Market

Jim Collins
Feb 25, 2021 1:52 PM EST

Let's look at the move in bonds, how it will lead stocks -- and load the deck with some 'b-sides.'

Jim Cramer: The Bond Market Vigilantes Strike

Jim Cramer
Feb 25, 2021 1:41 PM EST

What does that mean for stocks? Consider Nvidia.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:31 PM EST PETER WILLSON

    Has the Short-Term Top Come for the XLF/Banks?

    The has triggered a long-term overbought signal ...
  • 10:10 AM EST GARY BERMAN

    DLTR: The Buck Might Not Stop Here, but I Am Looking for a Bounce

    Dollar Tree is trading inside our long-term boun...
  • 08:36 AM EST GARY BERMAN

    Wednesday Morning Fibocall for 2/24/2021

    SPX (Long-Term View) The 2/16 HIGH @ 3950.43 is ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login